Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance

被引:65
|
作者
Wang, Tongxin [1 ,2 ]
Chen, Kai [3 ]
Yao, Weilei [1 ,2 ]
Zheng, Ruilong [4 ]
He, Qiongyu [1 ,2 ]
Xia, Jun [1 ,2 ]
Li, Juan [1 ,2 ]
Shao, Yafei [1 ,2 ]
Zhang, Li [1 ,2 ]
Huang, Lu [1 ,2 ]
Qin, Longshan [1 ,2 ]
Xu, Mingming [1 ,2 ]
Zhang, Zheng [1 ,2 ]
Pan, Dingyu [5 ]
Li, Zhen [5 ]
Huang, Feiruo [1 ,2 ,6 ]
机构
[1] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan 430070, Peoples R China
[2] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430071, Peoples R China
[4] Wageningen Univ & Res, Dept Anim Sci, Anim Nutr Grp, De Elst 1, NL-6708 WD Wageningen, Netherlands
[5] Wuhan Univ, Zhongnan Hosp, Dept Hepatobiliary & Pancreat Surg, Donghu Rd 169, Wuhan 430071, Peoples R China
[6] Huazhong Agr Univ, Minist Educ, Key Lab Environm Correlat Dietol, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
PCAF; LDHB; Acetylation; Hepatic lactate clearance; NAFLD; FATTY LIVER-DISEASE; LYSINE ACETYLATION; OXIDATIVE STRESS; METABOLISM; MICE;
D O I
10.1016/j.jhep.2020.11.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Lactate has recently been reported to accumulate in the livers of patients progressing from simple steatosis to non-alcoholic steatohepatitis (NASH). However, the underlying mechanism(s) of lactate accumulation and the role of lactate in the progression of non-alcoholic fatty liver disease (NAFLD) are essentially unknown. Methods: We compared the acetylome in liver samples taken from healthy individuals, patients with simple steatosis and patients with NASH to identify potential targets of acetylation with a role in lactate metabolism. Interactions between the acetylated target and acetyltransferases were measured in multiple cell lines. An acetyltransferase inhibitor was injected into high-fat diet (HFD)-fed mice to determine the role of lactate on NAFLD progression in vivo. Results: Hyperacetylation of lactate dehydrogenase B (LDHB) was found to be associated with lactate accumulation in NAFL and NASH livers in humans and mice. P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB K82 was found to significantly decrease LDHB activity and impair hepatic lactate clearance, resulting in lactate accumulation. Acetylated LDHB induced lactate accumulation which exacerbated lipid deposition and inflammatory responses by activating histone hyperacetylation in HFD-induced NASH. The administration of embelin, a PCAF inhibitor, and the generation of an acetylation-deficient mutant of LDHB ameliorated NASH. Conclusion: PCAF-dependent LDHB acetylation plays a key role in hepatic lipid accumulation and inflammatory responses by impairing lactate clearance; this process might be a potential therapeutic target for the treatment of NASH. Lay summary: Lactate is known to accumulate in the livers of patients during the progression of non-alcoholic fatty liver disease (NAFLD); however, the underlying mechanism(s) of this accumulation and its importance in disease progression are unknown. Herein, we show that the acetylation of an enzyme involved in lactate metabolism leads to impaired lactate clearance and exacerbates NAFLD progression. (C) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1038 / 1052
页数:15
相关论文
共 50 条
  • [41] Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression
    Khan, Fatima
    Lin, Yiyun
    Ali, Heba
    Pang, Lizhi
    Dunterman, Madeline
    Hsu, Wen-Hao
    Frenis, Katie
    Rowe, R. Grant
    Wainwright, Derek A.
    Mccortney, Kathleen
    Billingham, Leah K.
    Miska, Jason
    Horbinski, Craig
    Lesniak, Maciej S.
    Chen, Peiwen
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells
    Manerba, Marcella
    Di Ianni, Lorenza
    Govoni, Marzia
    Comparone, Anton Ietta
    Di Stefano, Giuseppina
    PLOS ONE, 2018, 13 (08):
  • [43] Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma
    Li, Juan
    Zhu, Shuchai
    Tong, Jing
    Hao, Hui
    Yang, Jie
    Liu, Zhikun
    Wang, Yuxiang
    NEUROREPORT, 2016, 27 (02) : 110 - 115
  • [44] Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma
    Chen, Xiao-Yong
    Chen, Jin-Yuan
    Chen, Yue
    Chen, Jia-Fang
    Lin, Ni
    Ding, Chen-Yu
    Kang, De-Zhi
    Wang, Deng-Liang
    Fang, Wen-Hua
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 209
  • [45] DETECTION OF LACTATE-DEHYDROGENASE B-4 IN HUMAN HEMOLYSATE OF PATIENTS DEFICIENT IN LACTATE DEHYDROGENASE-B SUBUNIT ACTIVITY USING ENZYME-IMMUNOASSAY
    SUDO, K
    MAEKAWA, M
    KANNO, T
    BIOCHEMICAL GENETICS, 1986, 24 (7-8) : 625 - 633
  • [46] FIRST STEPS OF LACTATE OXIDATION BY BAKERS-YEAST L-(+)-LACTATE DEHYDROGENASE (CYTOCHROME B2)
    LEDERER, F
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1974, 46 (02): : 393 - 399
  • [47] Dynamics of NADH Cofactor Binding to B. Stearothermophilus Lactate Dehydrogenase
    Zhadin, Nickolay
    Lodewyks, Kara
    Nie, Beining
    Desamero, Ruel
    Callender, Robert
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 50A - 50A
  • [48] Identification of the first highly selective inhibitor of human lactate dehydrogenase B
    Sachio Shibata
    Satoshi Sogabe
    Masanori Miwa
    Takuya Fujimoto
    Nobuyuki Takakura
    Akihiko Naotsuka
    Shuji Kitamura
    Tomohiro Kawamoto
    Tomoyoshi Soga
    Scientific Reports, 11
  • [49] Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis
    Zha, Xiaojun
    Wang, Fang
    Wang, Ying
    He, Shaozong
    Jing, Yanling
    Wu, Xueyan
    Zhang, Hongbing
    CANCER RESEARCH, 2011, 71 (01) : 13 - 18
  • [50] Identification of yak lactate dehydrogenase B gene variants by gene cloning
    YuCai Zheng
    XingBo Zhao
    Jing Zhou
    Ying Piao
    SuYu Jin
    QingHua He
    Jian Hong
    Ning Li
    ChangXin Wu
    Science in China Series C: Life Sciences, 2008, 51 : 430 - 434